At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

Acadia to Host Conference Call and Webcast on Wednesday, November 4, 2020 , at 4:30 p.m. Eastern Time   SAN DIEGO --(BUSINESS WIRE)--Oct. 21, 2020-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesday, November 4, 2020 , after
ATLANTA & SAN DIEGO --(BUSINESS WIRE)--Oct. 14, 2020-- The Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an exclusive partnership on the production and release of a disease education adaptation of the new film Robin’s Wish © , a documentary
  Partnership provides educational resources on navigating cognitive changes to people with Parkinson’s and their care partners  Among the estimated 6 million people worldwide with Parkinson’s, many say thinking and memory changes — ranging from mild cognitive impairment to dementia — are among the